Kriti Nutrients Ltd. Holds 30th AGM, Approves Financials and Dividend
Kriti Nutrients Limited held its 30th AGM on August 12, 2026, approving audited standalone and consolidated financial statements for FY26. The interim dividend of ₹3.00 per share was confirmed. Key appointments and re-appointments of directors and auditors were also approved.
The approval of financial statements, dividend, and re-appointments are routine yet important for stakeholder confidence and operational continuity.
The company successfully conducted its AGM, approved financial statements, confirmed dividend payment, and re-appointed key personnel and auditors, indicating smooth corporate governance.
Kriti Nutrients Limited announced the outcome of its 30th Annual General Meeting (AGM) held on Wednesday, August 12, 2026. The meeting, conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM), concluded at 5:02 PM.
During the AGM, members duly approved several resolutions. These included the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Balance Sheet, Statement of Profit & Loss, Statement of Cash Flow, and notes thereto. The reports of the Board of Directors and Auditors were also approved.
Furthermore, the members confirmed the interim dividend of ₹3.00 (300%) per equity share of ₹1 each for the financial year ended March 31, 2026. The AGM also saw the approval for the re-appointment of Mr. Saurabh Singh Mehta as a director, who retires by rotation. The reappointment of M/s. Mehta & Company as Statutory Auditors and the ratification of remuneration for the Cost Auditors, M/s. Dhananjay V. Joshi & Associates for the year 2026-27 were also confirmed.
Additionally, resolutions were passed for the confirmation of revision in remuneration for Mr. Saurabh Singh Mehta, designated as Joint Managing Director, and the reappointment and fixing of remuneration for Mr. Shiv Singh Mehta as Chairman and Managing Director, and Mr. Saurabh Singh Mehta as Whole-time Director designated as Joint Managing Director.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.